These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32095079)

  • 1. Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Li N
    Onco Targets Ther; 2020; 13():827-840. PubMed ID: 32095079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
    Hu B; Tian X; Sun J; Meng X
    Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of alpha-fetoprotein,
    Song T; Wang L; Su B; Zeng W; Jiang T; Zhang T; Sun G; Wu H
    J Int Med Res; 2020 Mar; 48(3):300060519889270. PubMed ID: 31852373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
    Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
    Song T; Wang L; Xin R; Zhang L; Tian Y
    J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma.
    Pang BY; Leng Y; Wang X; Wang YQ; Jiang LH
    Ann Med; 2023 Dec; 55(1):42-61. PubMed ID: 36476015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.
    Li GJ; Chen QY; Harrison TJ; Wang XY; Hu LP; Yang QL; Li KW; Fang ZL
    Cancer Biomark; 2017; 18(3):241-248. PubMed ID: 28085009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
    Jing JS; Ye W; Jiang YK; Ma J; Zhu MQ; Ma JM; Zhou H; Yu LQ; Yang YF; Wang SC
    Clin Lab; 2017 Nov; 63(11):1903-1909. PubMed ID: 29226636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Jia X; Liu J; Gao Y; Huang Y; Du Z
    Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.
    Xu D; Su C; Sun L; Gao Y; Li Y
    Ann Hepatol; 2019; 18(1):58-67. PubMed ID: 31113610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
    Xu WJ; Guo BL; Han YG; Shi L; Ma WS
    Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
    Xu C; Yan Z; Zhou L; Wang Y
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.
    Chen H; Zhang Y; Li S; Li N; Chen Y; Zhang B; Qu C; Ding H; Huang J; Dai M
    Cancer Manag Res; 2018; 10():1947-1958. PubMed ID: 30022853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians.
    Gomaa SH; Abaza MM; Elattar HA; Amin GA; Elshahawy DM
    Arab J Gastroenterol; 2020 Dec; 21(4):224-232. PubMed ID: 32891543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G; Dong F; Xu X; Hu A; Hu Y
    Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression.
    Li J; Qiyu S; Wang T; Jin B; Li N
    Open Life Sci; 2019 Jan; 14():53-61. PubMed ID: 33817137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.